Pediatric Hematology · Congenital Sideroblastic Anemia

Understanding Your Infant's Congenital Sideroblastic Anemia

At a Glance

Congenital sideroblastic anemia is an inherited disorder in which an infant's red blood cells cannot use iron normally to make hemoglobin. Specialists use genetic testing, bone marrow findings, and iron monitoring to plan transfusions and assess whether severe disease warrants transplant evaluation.

Receiving a diagnosis of Congenital Sideroblastic Anemia (CSA) for your infant is often a moment of profound shock and overwhelming worry ^[1]. It is natural to feel a sense of grief or even guilt as you navigate the reality of a rare genetic condition ^[2]. Please know that these feelings are a common response to the uncertainty that comes with a rare disease diagnosis ^[3], and importantly, an inherited condition is not caused by anything a parent did. While this journey is unexpected, there is a dedicated medical community and a clear framework for managing your child’s health.

The Biology of “Trapped Iron”

To understand CSA, it helps to look inside your child’s developing red blood cells (called erythroblasts) in the bone marrow. Normally, the body uses iron to create hemoglobin, the protein that carries oxygen to every part of the body. In the most common severe form of infant CSA (often caused by a mutation in the SLC25A38 gene), the mitochondria—the energy centers of the cell—have a defective transporter that cannot bring in enough of a key amino acid called glycine ^[4].

Without enough glycine entering the mitochondria, an early step in making heme (the “iron” part of hemoglobin) stalls ^[5]. Because the process is stalled, the iron that was supposed to be used for hemoglobin has nowhere to go. It becomes trapped inside the mitochondria, forming a circle around the nucleus of the developing cell ^[6]. When doctors look at the bone marrow under a microscope, they see these distinctive circles, which they call ring sideroblasts ^[7].

Because the iron is stuck and not being used to make hemoglobin, your child’s mature red blood cells are small, pale, and fewer in number, leading to the symptoms of anemia ^[8].

Why Rarity Requires Specialists

CSA is exceptionally rare, which presents a unique challenge for local pediatricians or general practitioners who may never see another case in their entire career. Because the condition is so specialized, your child needs a care team led by experts in pediatric hematology and genetics ^[9]^[10].

Specialists are essential for several reasons:

Precision Diagnosis: They use advanced Next-Generation Sequencing (NGS) to identify the exact genetic mutation causing the anemia, which helps guide expectations for how the disease might progress ^[11]^[12].
Distinguishing Causes: They must rule out other acquired causes of “ringed” cells in the marrow, such as lead poisoning or copper deficiency, to ensure the diagnosis is truly genetic ^[13].
Managing Iron Levels: Because the body keeps absorbing iron but cannot use it, children with CSA can develop iron overload even before they start receiving blood transfusions ^[14]. Specialists monitor this closely to protect vital organs like the heart and liver ^[15].
Coordinated Care: Some forms of CSA are syndromic, meaning they can affect other parts of the body, such as the immune system or growth ^[16]. Specialists coordinate with other doctors to ensure every aspect of your child’s health is watched ^[17].

Navigating the Path Ahead

While the diagnosis is heavy, there is a structured path forward. For some children, the goal is to manage the anemia with regular monitoring and, if needed, blood transfusions to keep their energy and growth on track ^[14]. For others with severe, transfusion-dependent forms of the disease, an early referral for a hematopoietic stem cell transplant (HSCT) evaluation may be considered ^[18].

You do not have to navigate this alone. Many parents find strength in connecting with rare-disease communities where they can share practical tips and emotional support with those who truly understand the “rare” experience ^[19]. Your medical team, including genetic counselors, is there to empower you with information, and together, you will build a plan that focuses on your child’s long-term health and quality of life ^[20].

Common questions in this guide

What is congenital sideroblastic anemia in an infant?

Congenital sideroblastic anemia is a rare inherited blood disorder in which developing red blood cells cannot use iron normally to make hemoglobin. This leaves iron trapped inside the cells and causes small, pale, and fewer red blood cells.

What does an SLC25A38 mutation mean for my baby?

An SLC25A38 mutation can cause a severe form of infant congenital sideroblastic anemia by disrupting a mitochondrial transporter needed to bring glycine into developing red blood cells. Genetic testing can confirm the mutation and help the care team discuss the expected disease course, but the result must be interpreted for the individual child.

How do doctors diagnose CSA, and what are ring sideroblasts?

Doctors may combine blood findings with a bone marrow examination. Ring sideroblasts are immature red blood cells with iron arranged in a ring around the nucleus, and advanced genetic testing can help identify the inherited cause; doctors also rule out lead poisoning and copper deficiency.

Can iron overload develop before an infant receives transfusions?

Yes. The body may continue absorbing iron even though the cells cannot use it properly, so iron overload can occur before transfusions begin. Specialists monitor iron and protect organs such as the heart and liver.

What treatments might an infant with CSA need?

Care may include regular monitoring and blood transfusions when anemia affects the child's health. Depending on the mutation, doctors may supervise a trial of pyridoxine (vitamin B6); severe transfusion-dependent disease may lead to an early evaluation for hematopoietic stem cell transplant.

Which specialists should care for an infant with CSA?

Because CSA is rare, an infant should be cared for by pediatric hematology and genetics specialists. If the condition is syndromic, the team may coordinate with other specialists to evaluate immune function, growth, or other affected body systems.

Is congenital sideroblastic anemia caused by something a parent did?

No. It is an inherited genetic condition and is not caused by anything a parent did. A genetic counselor can explain the genetic result and what it may mean for the family.

Get notified when new evidence is published on Severe congenital hypochromic anemia with ringed sideroblasts.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (20)

1
Understanding the Experiences and Needs of Parents With Children With Epidermolysis Bullosa. A Qualitative Study to Inform the Development of a Self-help Toolkit.
Hughes O, Martin F, Thompson AR
The British journal of dermatology 2026; doi:10.1093/bjd/ljag477.
PMID: 42952132
2
The burden of illness in Prader-Willi syndrome: a systematic literature review.
Dempsey D, Hall M, Lanning B, et al.
Orphanet journal of rare diseases 2025; (20(1)):374 doi:10.1186/s13023-025-03787-0.
PMID: 40708003
3
The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan.
LoPresti M, Igarashi A, Sonohara Y, Bowditch S
Epilepsy & behavior : E&B 2024; (158()):109932 doi:10.1016/j.yebeh.2024.109932.
PMID: 39029305
4
Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.
Lunetti P, Damiano F, De Benedetto G, et al.
The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.
PMID: 27476175
5
Anti-Correlation between the Dynamics of the Active Site Loop and C-Terminal Tail in Relation to the Homodimer Asymmetry of the Mouse Erythroid 5-Aminolevulinate Synthase.
Na I, Catena D, Kong MJ, et al.
International journal of molecular sciences 2018; (19(7)) doi:10.3390/ijms19071899.
PMID: 29958424
6
Iron Metabolism in the Disorders of Heme Biosynthesis.
Ricci A, Di Betto G, Bergamini E, et al.
Metabolites 2022; (12(9)) doi:10.3390/metabo12090819.
PMID: 36144223
7
Causes and Pathophysiology of Acquired Sideroblastic Anemia.
Rodriguez-Sevilla JJ, Calvo X, Arenillas L
Genes 2022; (13(9)) doi:10.3390/genes13091562.
PMID: 36140729
8
P2 Receptor Antagonists Rescue Defective Heme Content in an In Vitro SLC25A38-Associated Congenital Sideroblastic Anemia Cell Model.
Santoro A, De Santis S, Palmieri F, et al.
International journal of molecular sciences 2024; (25(24)) doi:10.3390/ijms252413314.
PMID: 39769087
9
Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.
Abu-Zeinah G, DeSancho MT
Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.
PMID: 33061728
10
Rare anemias due to genetic iron metabolism defects.
Brissot P, Bernard DG, Brissot E, et al.
Mutation research. Reviews in mutation research 2018; (777()):52-63 doi:10.1016/j.mrrev.2018.06.003.
PMID: 30115430
11
[Clinical features and gene mutation spectrum in children with sideroblastic anemia].
An WB, An WB, Liu C, et al.
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(10)):1016-1021.
PMID: 31642437
12
Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting.
Sharma P, Bhatia P, Singh M, et al.
The Journal of molecular diagnostics : JMD 2024; (26(5)):430-444 doi:10.1016/j.jmoldx.2024.01.011.
PMID: 38360212
13
When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.
Girard S, Genevieve F, Rault E, et al.
Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071752.
PMID: 35885655
14
Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.
Uminski K, Houston DS, Hartley JN, et al.
Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.
PMID: 32790119
15
Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M, Malcovati L
Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.
PMID: 26637696
16
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.
Fouquet C, Le Rouzic MA, Leblanc T, et al.
British journal of haematology 2019; (187(4)):530-542 doi:10.1111/bjh.16100.
PMID: 31338833
17
Children with a rare congenital genetic disorder: a systematic review of parent experiences.
von der Lippe C, Neteland I, Feragen KB
Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.
PMID: 36253830
18
Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience.
Shamsian BS, Jafari MR, Abolghasemi H, et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2023; (21(1)):70-75 doi:10.6002/ect.2022.0081.
PMID: 36757170
19
Social Media Use Among Parents and Caregivers of Children With Rare Genetic Diseases: Scoping Review.
Davis C, Bogaert L, Powell J, Low K
Journal of medical Internet research 2025; (27()):e77087 doi:10.2196/77087.
PMID: 41313807
20
Survey of patient satisfaction with genetic counseling services in Korea.
Choi IH, Kim YK, Yang SY, et al.
Journal of genetic counseling 2025; (34(1)):e1922 doi:10.1002/jgc4.1922.
PMID: 38769825

This page is for informational purposes only and does not constitute medical advice about your infant's congenital sideroblastic anemia. Your child's pediatric hematologist and genetics team should interpret test results and recommend care.